FindTrial
Sign In

Study on multi-omics-based tumor heterogeneity analysis and prognosis prediction of cervical cancer

Study on multi-omics-based tumor heterogeneity analysis and prognosis prediction of cervical cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123515
Enrollment
Unknown
Registered
2026-04-27
Start date
2026-04-27
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Observational study:None

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Histopathologically confirmed diagnosis of cervical cancer; 2. OS and PFS at 1, 3, and 5 years after treatment.

Exclusion criteria

Exclusion criteria: 1. A history of concurrent malignant tumors or prior malignancies; 2. Incomplete or missing clinical follow-up data.

Design outcomes

Primary

MeasureTime frame
Overall Survival;Progression Free Survival;—

Countries

China

Contacts

Public ContactYue Feng

Zhejiang Cancer Hospital

fengyue@zjcc.org.cn+86 152 2406 5122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026